# acamprosate calcium

NDC: 68382-569
Generic name: acamprosate calcium
Labeler / Manufacturer: Zydus Pharmaceuticals (USA) Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20170601

FDA application: ANDA205995

## Active ingredients

- ACAMPROSATE CALCIUM: 333 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68382-569"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68382-569
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9803db35-2600-4f42-80c1-43216fd1ba3d